There was also an incentive
for vaccine manufacturers to sell more vaccine if boosters were recommended annually.
If the legal atmosphere becomes too difficult
for vaccine manufacturers, they could stop producing them or be forced out of business.
One application of sieve analysis, once it's learned that a vaccine's efficacy depends on the genetics of the pathogen, is
for the vaccine manufacturer to add a different strain or strains to the vaccine to increase its protectiveness.
Not exact matches
However (and incredibly), we may be on the verge of a
vaccine against nicotine addiction — how cigarette
manufacturers feel about that is certainly a matter
for speculation... A high carbohydrate lunch will make you sleepy and sluggish.
For example, I recall that the first sentence of that particular site was that
vaccine manufacturers don't list the ingredients of their product anywhere.
The shortage also has become an issue on the campaign trail, with Democratic candidate Sen. John Kerry blaming the Bush administration
for not paying attention to warning signs about possible shortages and the Bush campaign inferring that
vaccine manufacturers are hindered by fears of lawsuits, something the campaign said Kerry would not move to fix.
The only two
manufacturers of human rabies
vaccine approved
for use in the U.S. have experienced production interruptions and other problems that could result in a shortage, health officials warn.
It will enable
manufacturers to rapidly create and make available
vaccines for the seasonal flu and pandemic outbreaks.
Phages would require a less traditional approach to get official approval, such as the annual process
for influenza
vaccines in which
manufacturers secure approval of new formulas based on the flu bug that is going around that year, instead of conducting big clinical trials every time.
Why should India or China let their
manufacturers fill American orders
for these products if their countries are being denied access and can not afford
vaccine and drugs
for their own massive populations?
At this point, the U.S. government expects
manufacturers to deliver 45 million to 52 million doses of the
vaccine by mid-October, said Jay Butler, head of the H1N1 task force
for the U.S. Centers
for Disease Control and Prevention.
Supporters of the AMC concept say that it addresses an immediate problem by providing a reason
for manufacturers to provide pneumococcal
vaccines to needy populations.
Unlike other medical treatments
for which companies are driven to keep their products safe because of liability threats, their brief says «the
Vaccine Program itself provides no incentive to vaccine manufacturers to make their vaccines safer.
Vaccine Program itself provides no incentive to
vaccine manufacturers to make their vaccines safer.
vaccine manufacturers to make their
vaccines safer.»
Easter may have come and gone, but
manufacturers of flu
vaccines are always hunting
for eggs.
Vaccine manufacturers have notified officials that they can't make good on their targets, Anne Schuchat, director of CDC's National Center
for Immunization and Respiratory Diseases, said during a press conference today.
In a dissenting opinion, they accused the court of imposing «its own bare policy preferences» to protect
vaccine manufacturers and said it was important
for companies to be pushed, at times by litigation, to improve on existing
vaccines.
The case was closely watched on all sides because it challenged the 1986 National Childhood
Vaccine Injury Act (NCVIA); that act sought to protect manufacturers from a flood of liability claims — and thereby stabilize the vaccine market — but also preserve a family's right to be compensated for vaccine in
Vaccine Injury Act (NCVIA); that act sought to protect
manufacturers from a flood of liability claims — and thereby stabilize the
vaccine market — but also preserve a family's right to be compensated for vaccine in
vaccine market — but also preserve a family's right to be compensated
for vaccine in
vaccine injuries.
While conducting trials, researches also found that some
manufacturers» formulations
for their one - year and three - year rabies
vaccines were identical.
The Lancet and most of the article's coauthors ultimately disowned the study because its lead author had not divulged that he was also being paid to conduct research
for parents seeking to sue
vaccine manufacturers.
Dr Ho works in NIBSC since 1998 and leads R&D and standardisation projects collaborating with
vaccine manufacturers in laboratory evaluation of product characterisation and quality control assays
for novel bacterial
vaccines, including protein subunit, polysaccharide - protein conjugates, viral vector and live bacterial
vaccines.
«Because viruses typically mutate during
vaccine production,
manufacturers have to screen
for mutations, and decide which ones can be tolerated and which ones can't,» Heaton said.
Moving the Needle provides quarterly updates from PATH's Center
for Vaccine Innovation and Access (CVIA) on our vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
Vaccine Innovation and Access (CVIA) on our
vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
vaccine development efforts, as well as related supporting work, such as developing human challenge models, building capacity of developing - country
vaccine manufacturers, and evaluating new adjuvants and other novel vaccine techno
vaccine manufacturers, and evaluating new adjuvants and other novel
vaccine techno
vaccine technologies.
Wakefield,
for example, had received money from lawyers involved in lawsuits against
vaccine manufacturers.
The
vaccine label indication means that the
vaccine manufacturer can guarantee that the
vaccine will be fully effective
for at least that amount of time (12 months).
As it is, only a small percentage of the reactions are actually reported to the
vaccine manufacturers or to the Center
for Veterinary Biologics (CVB).
This recommendation is made based upon FDA approval
for these
vaccines and
manufacturer's label instructions.
The fact that vets and
vaccine manufacturers have a financial incentive
for urging us to get lots of shots
for our dogs didn't seem to occur to us.
Colorado State University Veterinary Teaching Hospital states ``... booster
vaccine recommendations
for vaccines other than rabies virus have been determined arbitrarily by
manufacturers.»
Many veterinarians still send pet owners reminders
for booster shots and justify that callous practice with
vaccine manufacturers» labeled recommendations.
Dr. Patricia Jordan, author of Mark of the Beast, writes about one
manufacturer's combo shot: ``... the absolutely worse adverse
vaccine reactions have been noted with... the «mumbo jumbo» polyvalent with several modified live viruses, killed whole bacterins of Leptospirosis, killed corona virus (the
vaccine looking
for a disease), lots of adjuvant, mercury, aluminum, antibacterial like gentocin, antifungal and fungi stats, proprietary ingredients of whose true identity makes me shudder to even speculate.»
Zoetis, which
manufacturers drugs and
vaccines for small and large animals, noted that Dr. Goldstein's research and clinical interests have focused on «improving the ability of veterinarians to detect and prevent genetic and infectious diseases in companion animals through the development of multiple novel diagnostic tests and
vaccines.»
There are currently two pharmaceutical
manufacturers that offer CIV
vaccines for the H3N8 and H3N2 strains.
Vaccine manufacturers have known the drawbacks of their leptospirosis
vaccines for years.
For humans, the
manufacturers change the
vaccines every year in an attempt to keep up with the mutations.
To ensure the best protection
for your pet, our protocols and
vaccine manufacturers are constantly updated using information from noted specialty boards, specialists, and organizations such as the American Animal Hospital Association.
Unfortunately
vaccine manufacturers haven't (yet) made it possible
for us to pick and choose the individual shots we would like our puppies to have.
Additional
vaccines are given based on either the
vaccine manufacturer's recommendations
for the particular
vaccine, as dictated by law, or your veterinarian's counsel.
Note: a
vaccine reaction, especially one supported by your vet, may entitle you to compensation
for medical expenses from the drug
manufacturer.
Cecil Metzger, a spokesman
for Norden Laboratories in Lincoln, Neb., one of the nation's largest
manufacturers of rabies
vaccines, said his company and others don't make blanket recommendations
for annual inoculations.
This contradicts what the
vaccine manufacturers report
for rates of adverse reactions, which is «less than 15 adverse reactions in 100,000 animals vaccinated» (0.015 percent).
The
vaccine manufacturers claim one year duration
for many of the bordetella
vaccines but other studies don't support this claim.
The profits
for vets pale in comparison to the profits being enjoyed by
vaccine manufacturers.
Current
manufacturer's recommendations are
for annual boosters
for cat
vaccines.
Vaccines for rattlesnake bites and periodontal disease should be administered per the
manufacturers» labels.
This agency is responsible
for reviewing
vaccine reaction reports and considers whether or not the
manufacturer must perform additional investigation.
We whose dogs have died or suffered chronic debilitating diseases shouldn't have to take their word
for it when the
vaccine manufacturers deny responsibility.
Wakefield had been secretly working
for lawyers, who were recruiting parents of autistic children to sue the
vaccine manufacturer.
Based on that information and on the recommendations of the FDA's
Vaccines and Related Biological Products Advisory Committee, the FDA selects the different influenza strains each year that manufacturers should include in their vaccines for the U.S. population for the upcoming influenza
Vaccines and Related Biological Products Advisory Committee, the FDA selects the different influenza strains each year that
manufacturers should include in their
vaccines for the U.S. population for the upcoming influenza
vaccines for the U.S. population
for the upcoming influenza season.